|
|
Gaucher's Disease
|
|
Gaucher's Disease
[an error occurred while processing this directive]
Chief Scientist: Genzyme mulling Israeli R&D center Nov 17, 2005
Genzyme currently markets 25 main products in over 60 countries. Its developments include an alternative enzyme for treatment of Gaucher's disease. ...
- Globes,
Aetna to Own 100 Percent of Aetna Specialty Pharmacy; Action taken ... Oct 26, 2005
...company's chronically ill members who suffer from diseases such as anemia, cancer, Crohn's Disease, cystic fibrosis, Gaucher's Disease, hemophilia, hepatitis ...
- Business Wire (press release),
Firm outlines the future of drugs Sep 23, 2005
...which allow companies advantageous terms to develop orphan drugs, but Genzyme led the way, initially with its cure for Gaucher's Disease, a painful and fatal ...
- Cambridge Evening News,
Genzyme's Myozyme Now On File, Seeking Priority ReviewJul 29, 2005
Already that formula has worked for Cerezyme (imiglucerase), the Gaucher's disease treatment that is approved in almost 80 countries, and Fabrazyme (agalsidase ...
- BioWorld Online (subscription)
Protalix gets FDA approval for clinical trialsJul 25, 2005
...(formerly Metabogal) has received US Food and Drug Administration (FDA) approval for Phase I clinical trials of its drug for treating Gaucher's disease. ...
- Globes Online
Source: Shire Pharmaceuticals Group PlcJul 27, 2005
...and Drug Administration expected before the end of this year, as well as the publication of phase 1 clinical data for GA-GCB, a treatment for Gaucher's disease ...
- Yahoo News
Israeli researchers find genetic basis for breast cancer in men ...Jul 21, 2005
...breast cancer. The other found that 25% of Ashkenazim with Parkinson's disease carry a gene that causes Gaucher's disease. Until ...
- Israel 21C
Market Report / Gentle rises after last week's stormsJul 24, 2005
BCEL) skyrocketed 10.4 percent on news that its subsidiary Protalix had received FDA approval to start clinical trials on its treatment for Gaucher's Disease. ...
- Ha'aretz
Protalix Biotherapeutics Raises $5.3 Million in Private Equity ...Jul 18, 2005
This powerful capability is validated by the aggressive progress of the company's lead drug for the treatment of Gaucher's disease into clinical trials. ...
- PharmaLive.com
Mannatech's sugar-coated moneymakerJul 16, 2005
...endeavour showing considerable promise in the development of cancer-fighting drugs and for the treatment of inherited disorders such as Gaucher's disease. ...
- New Zealand Herald
Genzyme Beats Estimates; Revenues Jump 22 PercentJul 14, 2005
...therapy for Fabry's disease, increased by 50 percent to $74.4 million, while Cerezyme, an enzyme-replacement therapy for Type I Gaucher's disease, totaled $236 ...
- BioWorld Online (subscription)
Genentech, Genzyme poised for higher earningsJul 7, 2005
...be a blockbuster," said Reames, adding it could eventually have higher sales than the company's lead drug Cerezyme, which is used to treat Gaucher's disease. ...
- MarketWatch
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Gaucher's Disease
you may want to try searching the Internet using the Google search box below.
|
|
|
